Management of female pelvic organ prolapse-Summary of the 2021 HAS guidelines.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 11 01 2023
accepted: 12 01 2023
pubmed: 20 1 2023
medline: 3 3 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

When a patient presents with symptoms suggestive of pelvic organ prolapse (POP), clinical evaluation should include an assessment of symptoms, their impact on daily life and rule out other pelvic pathologies. The prolapse should be described compartment by compartment, indicating the extent of the externalization for each. The diagnosis of POP is clinical. Additional exams may be requested to explore the symptoms associated or not explained by the observed prolapse. Pelvic floor muscle training and pessaries are non-surgical conservative treatment options recommended as first-line therapy for pelvic organ prolapse. They can be offered in combination and be associated with the management of modifiable risk factors for prolapse. If the conservative therapeutic options do not meet the patient's expectations, surgery should be proposed if the symptoms are disabling, related to pelvic organ prolapse, detected on clinical examination and significant (stage 2 or more of the POP-Q classification). Surgical routes for POP repair can be abdominal with mesh placement, or vaginal with autologous tissue. Laparoscopic sacrocolpopexy is recommended for cases of apical and anterior prolapse. Autologous vaginal surgery (including colpocleisis) is a recommended option for elderly and fragile patients. For cases of isolated rectocele, the posterior vaginal route with autologous tissue should be preferentially performed over the transanal route. The decision to place a mesh must be made in consultation with a multidisciplinary team. After the surgery, the patient should be reassessed by the surgeon, even in the absence of symptoms or complications, and in the long term by a primary care or specialist doctor.

Identifiants

pubmed: 36657614
pii: S2468-7847(23)00003-X
doi: 10.1016/j.jogoh.2023.102535
pii:
doi:

Types de publication

Practice Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102535

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of Competing Interest None.

Auteurs

Anne-Cécile Pizzoferrato (AC)

Department of Obstetrics and Gynaecology, La Miletrie University Hospital, Poitiers, France, INSERM CIC 1402, Poitiers University, Poitiers, France. Electronic address: anne-cecile.pizzoferrato@chu-poitiers.fr.

Caroline Thuillier (C)

Department of Urology, Grenoble Alpes University Hospital, Grenoble, France.

Aurélien Vénara (A)

Department of Digestive Surgery, Angers University Hospital, Angers, France.

Nicole Bornsztein (N)

General practice office, Evry France, College of General Medicine, Paris, France.

Sylvain Bouquet (S)

General practice office, Lamastre, France, College of General Medicine, Paris, France.

Mélanie Cayrac (M)

GYNEPOLE, Obstetrics and Gynecology Center, Montpellier, France.

Martine Cornillet-Bernard (M)

Mousseau clinic, Evry-Courcouronnes, France.

Odile Cotelle (O)

Department of Obstetrics and Gynaecology, AP-HP, GHU Sud, Antoine Béclère Hospital, Clamart, France.

Florence Cour (F)

Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.

Sophie Cretinon (S)

Department of Obstetrics and Gynaecology, AP-HP Louis Mourier Hospital, Colombes, France.

Pia De Reilhac (P)

Medical Gynecology Office, Nantes, France.

Jérôme Loriau (J)

Department of Digestive Surgery, St-Joseph Hospital, Paris, France.

Françoise Pellet (F)

French Association of Gougerot Sjögren and Dry Syndromes, Paris, France.

Marie-Aimée Perrouin-Verbe (MA)

Department of Urology, Nantes University Hospital, Nantes, France.

Anne-Gaëlle Pourcelot (AG)

Department of Gynecology and Obstetrics, AP-HP, GHU-Sud, Bicêtre Hospital, Le Kremlin Bicêtre, France.

Christine Revel-Delhom (C)

Clinical practice guidelines Unit, French National Authority for Health, Saint Denis La Plaine, France.

Benoit Steenstrup (B)

Department of Urology, Rouen University Hospital, Rouen, France.

Thomas Vogel (T)

Geriatric Department, University Hospital of Strasbourg, Strasbourg, France.

Loïc Le Normand (L)

Department of Urology, Nantes University Hospital, Nantes, France.

Xavier Fritel (X)

Department of Obstetrics and Gynaecology, La Miletrie University Hospital, Poitiers, France, INSERM CIC 1402, Poitiers University, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH